Nuno Abecassis
Impact in
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
-
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Sarcoma Diagnosis and Treatment 7
- Gastric Cancer Management and Outcomes 1
-
- Bone Tumor Diagnosis and Treatments 2
- Soft tissue tumor case studies 1
- Journals
- Annals of Oncology (6 papers)Diagnostic Cytopathology (1 paper)PubMed (1 paper)
- Partner nations
- ItalyNetherlandsUnited Kingdom
In The Last Decade
Nuno Abecassis
9 papers receiving 3.6k citations
Nuno Abecassis's Hit Papers
Peers
Comparison fields: 5 of 85
- Gastroenterology 889
- Pulmonary and Respiratory Medicine 2.1k
- Rheumatology 484
- Oncology 746
- Cardiology and Cardiovascular Medicine 347
Countries citing papers authored by Nuno Abecassis
This map shows the geographic impact of Nuno Abecassis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuno Abecassis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuno Abecassis more than expected).
Fields of papers citing papers by Nuno Abecassis
This network shows the impact of papers produced by Nuno Abecassis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuno Abecassis. The network helps show where Nuno Abecassis may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2018 | 1096 |
| 2 | Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Hit paper breakdown → | 2021 | 690 |
| 3 | Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2018 | 598 |
| 4 | Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2018 | 436 |
| 5 | Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2021 | 371 |
| 6 | Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2021 | 303 |
| 7 | 2018 | 86 | |
| 8 | 1994 | 10 | |
| 9 | Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up | 2018 | 1 |
About Nuno Abecassis
Nuno Abecassis is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Gastroenterology, Cardiology and Cardiovascular Medicine and Oncology, having authored 9 papers that have together received 3.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (7 papers), Cardiac tumors and thrombi (3 papers), Bone Tumor Diagnosis and Treatments (2 papers), Gastrointestinal disorders and treatments (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Gastric Cancer Management and Outcomes (1 paper) and Soft tissue tumor case studies (1 paper). The work is most often cited by research in Gastroenterology (889 citations), Pulmonary and Respiratory Medicine (2.1k citations), Rheumatology (484 citations), Oncology (746 citations) and Cardiology and Cardiovascular Medicine (347 citations). Nuno Abecassis has collaborated with scholars based in Italy, Netherlands and United Kingdom. Their work appears in journals such as Annals of Oncology, Diagnostic Cytopathology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.